|Bid||76.31 x 800|
|Ask||77.86 x 900|
|Day's Range||75.77 - 76.98|
|52 Week Range||53.22 - 80.59|
|Beta (5Y Monthly)||0.54|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 27, 2022 - May 02, 2022|
|Forward Dividend & Yield||2.16 (2.85%)|
|Ex-Dividend Date||Mar 31, 2022|
|1y Target Est||79.16|
Three little words can make you a lot of money over the long term: Buy and hold. Here's why they picked AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Vertex Pharmaceuticals (NASDAQ: VRTX). Prosper Junior Bakiny (AbbVie): Pharma giant AbbVie is currently defying gravity.
Bristol Myers Squibb and Bluebird Bio have drugs in their pipelines that could soon earn FDA approval.
Bristol Myers Squibb (BMY) closed the most recent trading day at $76.84, moving -0.21% from the previous trading session.